Anticipated and Perceived Benefits Following Hepatitis C Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-31

Study Completion Date

2018-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is both qualitative and quantitative, gathering patient's perceptions of HCV treatment benefits before and after HCV treatment by administering surveys and conducting in-depth qualitative patient interviews. The study seeks to understand all anticipated and actual benefits patients perceive before and after viral eradication.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy Patients

NCT03057236

Hepatitis C Hepatitis C, Chronic

COMPLETED NA

Natural History of Hepatitis C in Patients With Normal Liver Tests

NCT00187473

Chronic Hepatitis C

COMPLETED

Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?

NCT01159613

Chronic Hepatitis C Viral Infection

COMPLETED

Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C

NCT02006823

Chronic Hepatitis C

COMPLETED

Conquering Hepatitis C Via Micro-Elimination in Southwest Virginia

NCT03876470

Hepatitis C

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study employs a mixed methods (qualitative and quantitative) pre-post study design utilizing in-depth qualitative interviews and patient reported outcome surveys. Pre-treatment surveys and interviews will be conducted before HCV therapy commences to understand all potential psychological, social, physical and medical consequences perceived to be related to HCV and the patients' anticipation (hope for) of improvements in these factors after viral eradication. Post-treatment surveys and interviews will occur 4 to 8 months after treatment ends to examine long-term treatment benefits, i.e., changes in HCV-related factors, such as symptoms, functioning, and health status.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatitis C Hepatitis C, Chronic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 21 or older
* English-speaking
* Any genotype
* Any treatment duration (e.g. 8, 12, or 24 weeks)
* Has been written a prescription for a sofosbuvir (SOF)-containing regimen.